Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event

Contributed by: Business Wire

Logo

Images

Copyrights - Sylvain Granjon

Copyrights - Sylvain Granjon

Copyrights - Sylvain Granjon

Business Wire embedded0

Tags

Science

Biotechnology

Research

Pharmaceutical

Managed Care

Health

Clinical Trials

Other Health

Galderma

More Like This

AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community

Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership

IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics

AMWC 2024: Galderma to Share New Data From Its Leading Injectable Aesthetic Portfolio

AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

AMWC Dubai: Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education